Clinical Trial Update: Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of iloperidone for acute treatment of manic or mixed episodes in Bipolar I Disorder has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Iloperidone (iloperidone)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-04-16